Ascentage Pharma Group International (AAPG) Other Non-Current Liabilities: 2023-2024
Historic Other Non-Current Liabilities for Ascentage Pharma Group International (AAPG) over the last 2 years, with Dec 2024 value amounting to $860,000.
- Ascentage Pharma Group International's Other Non-Current Liabilities fell 66.16% to $860,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $860,000, marking a year-over-year decrease of 66.16%. This contributed to the annual value of $860,000 for FY2024, which is 66.79% down from last year.
- As of FY2024, Ascentage Pharma Group International's Other Non-Current Liabilities stood at $860,000, which was down 66.79% from $2.6 million recorded in FY2023.
- Over the past 5 years, Ascentage Pharma Group International's Other Non-Current Liabilities peaked at $2.6 million during FY2023, and registered a low of $860,000 during FY2024.
- In the last 2 years, Ascentage Pharma Group International's Other Non-Current Liabilities had a median value of $1.7 million in 2023 and averaged $1.7 million.
- Data for Ascentage Pharma Group International's Other Non-Current Liabilities shows a maximum YoY crashed of 66.79% (in 2024) over the last 5 years.
- Yearly analysis of 2 years shows Ascentage Pharma Group International's Other Non-Current Liabilities stood at $2.6 million in 2023, then slumped by 66.79% to $860,000 in 2024.